Rare and very rare adverse effects of clozapine

References

• StahlSEssential Psychopharmacology Neuroscientific Basis and Practical Applications (Essential Psychopharmacology Series)CambridgeCambridge University Press2008
   Google Scholar
• Indanpaan-HeikkilaJAlhavaEOlkinuoraMPalvaIPAgranulocytosis during treatment with clozapineEur J Clin Pharmacol1977113193198856603
   PubMed Web of Science ®Google Scholar
• KaneJHonigfeldGSingerJMeltzerHClozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazineArch Gen Psychiatry19884597897963046553
   PubMed Web of Science ®Google Scholar
• SolankiRKSinghPMunshiDCurrent perspectives in the treatment of resistant schizophreniaIndian J Psychiatry200951425426020048449
   PubMedGoogle Scholar
• TaylorSElectroconvulsive therapy: a review of history, patient selection, technique, and medication managementSouth Med J2007100849449817534086
   PubMed Web of Science ®Google Scholar
• MalhotraAKPharmacogenomics and schizophrenia: clinical implicationsPharmacogenomics J20011210911411911437
   PubMedGoogle Scholar
• KaneJHonigfeldGSingerJMelzerHthe Clozaril Collaborative Study GroupClozapine for treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine/benztropineArch Gen Psychiatry19984597897963046553
   PubMed Web of Science ®Google Scholar
• GareriPDe FazioPRussoEMariglianoNDe FazioSDe SarroGThe safety of clozapine in the elderlyExpert Opin Drug Saf20087552553818759705
   PubMed Web of Science ®Google Scholar
• KumraSKranzlerHGerbino-RosenGClozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparisonBiol Psychiatry200863552452917651705
   PubMed Web of Science ®Google Scholar
• MeltzerHYMcGurkSRThe effects of clozapine, risperidone, and olanzapine on cognitive function in schizophreniaSchizophr Bull199925223325510416729
   PubMed Web of Science ®Google Scholar
• LindenmayerJPIskanderAParkMClinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective studyJ Clin Psychiatry199859105215279818633
   PubMed Web of Science ®Google Scholar
• BrarJSChengappaKNParepallyHThe effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptomsAnn Clin Psychiatry1997942272349511946
   PubMedGoogle Scholar
• GareriPDe FazioPDe FazioSNorma MariglianoNFerreri IbbaduGDe SarroGAdverse effects of atypical antiphychotics in the elderlyDrugs Aging2006231293795617154659
   PubMed Web of Science ®Google Scholar
• MelzerHYMatsubaraSLeeJCClassification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi valuesJ Pharmacol Exp Ther198925112382462571717
   PubMed Web of Science ®Google Scholar
• KapurSSeemanPDoes fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesisAm J Psychiatry2001158336036911229973
   PubMed Web of Science ®Google Scholar
• SongCLinAKenisGBosmansEMaesMImmunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonistSchizophr Res200042215716410742653
   PubMed Web of Science ®Google Scholar
• PatersonGJOhashiYReynoldsGPPrattJAMorrisBJSelective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugsJ Psychopharmacol200620563664216478754
   PubMed Web of Science ®Google Scholar
• GrossAJoffeGJoutsiniemiSLNybergPRimόnRAppelbergBDecreased production of reactive oxygen species by blood monocytes caused by clozapine correlates with EEG slowing in schizophrenic patientsNeuropsychobiology2003472737712707488
   PubMed Web of Science ®Google Scholar
• CohenSAUnderwoodMTThe use of clozapine in a mentally retarded and aggressive populationJ Clin Psychiatry199455104404447961521
   PubMed Web of Science ®Google Scholar
• FriedmanJHParkinson disease psychosis: updateBehav Neurol201327446947723242358
   PubMed Web of Science ®Google Scholar
• WalkerAMLanzaLLArellanoFRothmanKJMortality in current and former users of clozapineEpidemiology1997866716779345668
   PubMed Web of Science ®Google Scholar
• KruppPBarnesPClozapine-associated agranulocytosis: risk and aetiologyBr J Psychiatry Suppl19921738401418887
   PubMedGoogle Scholar
• YoungCRBowersMBMazureCMManagement of the adverse effects of clozapineSchizophr Bull19982433813909718630
   PubMed Web of Science ®Google Scholar
• GardnerDMBaldessariniRJWaraichPModern antipsychotic drugs: a critical overviewCMAJ2005172131703171115967975
   PubMed Web of Science ®Google Scholar
• Farmaciemedici.it [homepage on the Internet]A.I.F.A. [updated June 6, 2014] Available from: http://www.farmaciemedici.it/farmaci/bugiardino/leponex/aifa/Accessed February 19, 2015
   Google Scholar
• KamphuisHArendsJTimmermanLvan MarleJKappertJMyocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapyTijdschr Psychiatr201052422323320503163
   PubMedGoogle Scholar
• CrewsMPDhillonGSMacCabeJHClozapine rechallenge following clozapine-induced pericarditisJ Clin Psychiatry201071795996120667298
   PubMed Web of Science ®Google Scholar
• RathoreSMasaniNDCallaghanPOClozapine-induced effuso-constrictive pericarditisCase report and review of the literature. Cardiology200710818318517085936
   PubMed Web of Science ®Google Scholar
• AlawamiMWasywichCCicovicAKenediCA systematic review of clozapine induced cardiomyopathyInt J Cardiol2014176231532025131906
   PubMed Web of Science ®Google Scholar
• LambertiJSOlsonDCrillyJFPrevalence of the metabolic syndrome among patients receiving clozapineAm J Psychiatry200616371273127616816234
   PubMed Web of Science ®Google Scholar
• SaffermanALiebermanJKaneJSzymanskiSKinonBUpdate on the clinical efficacy and side effects of clozapineSchizophr Bull19911722472611882209
   PubMed Web of Science ®Google Scholar
• NaheedMGreenBFocus on clozapineCurr Med Res Opin200117322322911900316
   PubMed Web of Science ®Google Scholar
• VelayudhanRKakkanSLate onset clozapine induced agranulocytosisIndian J Psychol Med201436442542725336778
   PubMedGoogle Scholar
• AlvirJMLiebermanJAAgranulocytosis: incidence and risk factorsJ Clin Psychiatry199455suppl B1371387961558
   PubMed Web of Science ®Google Scholar
• LakerMCooksonJReflux oesophagitis and clozapineInt Clin Psychopharmacol199712137399179632
   PubMed Web of Science ®Google Scholar
• TownsendGCurtisDCase report: rapidly fatal bowel ischaemia on clozapine treatmentBMC Psychiatry200664317052340
   PubMed Web of Science ®Google Scholar
• RegeSLaffertyTLife-threatening constipation associated with clozapineAustralas Psychiatry200816321621918568631
   PubMed Web of Science ®Google Scholar
• PalmerSEMcLeanRMEllisPMHarrison-WoolrychMLife-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 casesJ Clin Psychiatry200869575976818452342
   PubMed Web of Science ®Google Scholar
• LiebermanJASaffermanAZPollackSClinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcomeAm J Psychiatry199415112174417527977880
   PubMed Web of Science ®Google Scholar
• HayesGGiblerBClozapine-induced constipation (letter)Am J Psychiatry199515222987840373
   PubMed Web of Science ®Google Scholar
• AlexopoulosGSStreimJCarpenterDDochertyJPExpert Consensus Panel for Using Antipsychotic Drugs in Older PatientsUsing antipsychotic agents in older patientsJ Clin Psychiatr200465suppl 2599
   PubMed Web of Science ®Google Scholar
• HolzerPAhmedzaiSHNiederleNOpioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its managementJ Opioid Manag20095314515119662924
   PubMedGoogle Scholar
• BakerDEMethylnaltrexone bromide: new drug for the treatment of opioid induced bowel dysfunctionRev Gastroenterol Disord200993E84E9319898269
   PubMedGoogle Scholar
• OnaliPOlianasMCN-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptorsNeuropsychopharmacology200732477378516841075
   PubMed Web of Science ®Google Scholar
• TomerTJonathanBAlanMDeath from clozapine-induced constipation: case report and literature reviewPsychosomatics2002431717311927763
   PubMed Web of Science ®Google Scholar
• Van SoestEDielemanJKuipersEThe effect of anticholinergic agents on gastrooesophageal reflux and related disordersExpert Opin Drug Saf20087217318018324880
   PubMed Web of Science ®Google Scholar
• PraharajSKAroraMGandotraSClozapine-induced sialorrhea: pathophysiology and management strategiesPsychopharmacology (Berl)2006185326527316514524
   PubMed Web of Science ®Google Scholar
• BakerRWChengappaKNGastroesophageal reflux as a possible result of clozapine treatmentJ Clin Psychiatry19985952579632041
   PubMed Web of Science ®Google Scholar
• van VeggelMOlofinjanaODaviesGTaylorDClozapìne and gastrooesophageal reflux disease (GORD) – an investigation of temporal associationActa Psychiatr Scand20121271697722901096
   PubMed Web of Science ®Google Scholar
• TaylorDOlofinjanaORahimiTUse of antacid medication in patients receiving clozapine: a comparison with other second generation antipsychoticsJ Clin Psychopharmacol201030446046120631564
   PubMed Web of Science ®Google Scholar
• de BruinGJBacDJvan PuijenbroekEPvan der KloosterJMOgilvie Syndrome induced by clozapineNed Tijdschr Geneeskd2009153B43720051163
   PubMedGoogle Scholar
• SaundersMDKimmeyMBSystematic review: acute colonic pseudo-obstructionAliment Pharmacol Ther2005221091792516268965
   PubMed Web of Science ®Google Scholar
• DworkinRHPain insensitivity in schizophrenia: a neglected phenomenon and some implicationsSchizophr Bull19942022352488085127
   PubMed Web of Science ®Google Scholar
• BickerstaffLKHarrisSCLeggettRSCheahKCPain insensitivity in schizophrenic patientsA surgical dilemma. Arch Surg1988123149513337657
   PubMedGoogle Scholar
• RosenthalSHPorterKACoffeyBPain insensitivity in schizophreniaCase report and review of the literature. Gen Hosp Psychiatry19901253193222210350
   PubMed Web of Science ®Google Scholar
• PotvinSStipETempierAPain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitizationPsychiatr Res2008421210101016
   Web of Science ®Google Scholar
• KeoghaneSRSullivanMEMillerMAThe aetiology, pathogenesis and management of priapismBJU Int200290214915412081756
   PubMed Web of Science ®Google Scholar
• ReifRVýbornýKPriapism: a urological emergencyActa Univ Palacki Olomuc Fac Med199313559637976678
   PubMedGoogle Scholar
• ComptonMTMillerAHSexual side effects associated with conventional and atypical antipsychoticsPsychopharmacol Bull20013538910812397881
   PubMedGoogle Scholar
• SeftelASaenz de TejadaISzetelaBColeJGoldsteinIClozapine-associated priapism: a case reportJ Urol199214711461481729510
   PubMed Web of Science ®Google Scholar
• MulhallJPKaminetskyJCAlthofSECorrelations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunctionAm J Mens Health20115326127121406491
   PubMed Web of Science ®Google Scholar
• HanesALee DemlerTLeeCCamposAPseudoephedrine for the treatment of clozapine-induced incontinenceInnov Clin Neurosci2013104333523696957
   PubMedGoogle Scholar
• Harrison-WoolrychMSkeggKAshtonJHerbisonPSkeggDCNocturnal enuresis in patients taking clozapine, risperidone, olanzapine, and quetiapine: comparative cohort studyBr J Psychiatry2011199214014421653944
   PubMed Web of Science ®Google Scholar
• LinCCBaiYMChenJYLinCYLanCYLanTHA retrospective of clozapine and urinary incontinence in Chinese in-patientsActa Psychatr Scand19991002158161
   Web of Science ®Google Scholar
• FullerMABorovickaMCJaskiwGESimonMRKwonKKonickiPEClozapine-induced urinary incontinence: incidence and treatment with ephedrineJ Clin Psychiatry199657115145188968299
   PubMed Web of Science ®Google Scholar
• WarnerJPHarveyCABarnesTRClozapine and urinary incontinenceInt Clin Psychopharmacol1994932072097814831
   PubMed Web of Science ®Google Scholar
• ThorKBDonatucciCCentral nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in womenJ Urol20041721273315201731
   PubMed Web of Science ®Google Scholar
• ClarkNConventional antipsychotic and clozapine-induced urinary incontinenceJ Coll Psychiatr Neurolog Pharma2003218
   Google Scholar
• MishraBSahooSSarkarSAkhtarSClozapine-induced angioneurotic edemaGen Hosp Psychiatry2007291788017189753
   PubMed Web of Science ®Google Scholar
• LaiYWChouCYShenWWLuMLPityriasis rosea-like eruption associated with clozapine: a case reportGen Hosp Psychiatry201234e5e7
   Google Scholar
• RaoAFrancisNMorarNClozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported casesBr J Dermatol201216651142114322121994
   PubMed Web of Science ®Google Scholar
• SrihariVHLeeTWPulmonary embolism in a patient taking clozapineBMJ200833676591499150118583682
   PubMed Web of Science ®Google Scholar
• TrippACNon-fatal pulmonary embolus associated with clozapine treatment: a case seriesGen Hosp Psychiatry2011331e5e621353146
   PubMed Web of Science ®Google Scholar
• JoksovicPMChilesCCardiac arrest and pulmonary embolism after clozapine titrationPrim Care Companion CNS Disord2011132MC3184584
   Google Scholar
• MunoliRNPraharajSKBhatSMClozapine-induced recurrent pulmonary thromboembolismJ Neuropsychiatry Clin Neurosci2013253E50E5124026744
   PubMed Web of Science ®Google Scholar
• HäggSJönssonAKSpigsetORisk of venous thromboembolism due to antipsychotic drug therapyExpert Opin Drug Saf20098553754719569978
   PubMed Web of Science ®Google Scholar
• PaciulloCAEvaluating the association between clozapine and venous thromboembolismAm J Health Syst Pharm200865191825182918796423
   PubMed Web of Science ®Google Scholar
• ZornbergGLJickHAntipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyLancet200035692371219122311072939
   PubMed Web of Science ®Google Scholar
• ParkinLSkeggDCHerbisonGPPaulCPsychotropic drugs and fatal pulmonary embolismPharmacoepidemiol Drug Saf200312864765214762980
   PubMed Web of Science ®Google Scholar
• DavidsonMKahnRSSternRGTreatment with clozapine and its effect of plasma homovanillic acid and norepinephrine concentrations in schizophreniaPsychiatry Res19934621511638483974
   PubMed Web of Science ®Google Scholar
• BreierABuchananRWWaltripRWListwakSHolmesCGoldsteinDSThe effect of clozapine on plasma norepinephrine: relationship to clinical efficacyNeuropsychopharmacology1994101178179790
   PubMed Web of Science ®Google Scholar
• PickarDOwenRRLitmanREKonickiEGutierrezRRapaportMHClinical and biologic response to clozapine in patients with schizophrenia: Cross-over comparison with fluphenazineArch Gen Psychiatry19924953453531375019
   PubMed Web of Science ®Google Scholar
• WaltherMMKeiserHRLinehanWMPheochromocytoma: evaluation, diagnosis, and treatmentWorld J Urol1999171353910096149
   PubMed Web of Science ®Google Scholar
• KrentzAJMikhailSCantrellPHillGMPseudophaeochromocytoma syndrome associated with clozapineBMJ20013227296121311358774
   PubMed Web of Science ®Google Scholar
• LiJKYeungVTLeungCMClozapine: a mimicry of phaeochromocytomaAust NZ J Psychiatry1997316889891
   PubMed Web of Science ®Google Scholar
• PrasadSEKennedyHGPseudophaeochromocytoma associated with clozapine treatmentIr J Psych Med200320132134
   Web of Science ®Google Scholar
• AkinsolaOOngKPseudophaeochromocytoma associated with Clozapine Therapy: a case reportAfr J Psychiatry2011145406408
   Google Scholar
• DurstRRaskinSKatzGZislinJDurstRPedal edema associated with clozapine useIsr Med Assoc J20002648548610897248
   PubMed Web of Science ®Google Scholar
• SockalingamSShammiCRemingtonGClozapine-induced hypersalivation: a review of treatment strategiesCan J Psychiatry200752637738417696024
   PubMed Web of Science ®Google Scholar
• BrodkinEPeltonGPriceLTreatment of clozapine-induced parotid gland swellingAm J Psychiatry199615234458610845
   PubMed Web of Science ®Google Scholar
• RobinsonDFennHYesavageJPossible association of parotitis with clozapineAm J Psychiatry199515222972987840372
   PubMed Web of Science ®Google Scholar
• BrooksKGThompsonDFA review and assessment of drug-induced parotitisAnn Pharmacother201246121688169923249870
   PubMed Web of Science ®Google Scholar
• ImmadisettyVAgrawalPA successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic reviewTher Adv Psychopharmacol20122623523923983982
   PubMedGoogle Scholar
• ReinsteinMSirotovskyaLChasonovMComparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapineClin Drug Investig19991797102
   Web of Science ®Google Scholar
• ConleyRRKellyDLSecond-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effectsIsr J Psychiatry Relat Sci2005421516016134407
   PubMed Web of Science ®Google Scholar
• ThéretLGermailMLBurdeACurrent aspects of the use of clozapine in the Chalons-surMarn Psychiatric Hospital: intestinal occlusion with clozapineAnn Med Psychol19951537474477
   Web of Science ®Google Scholar
• DrewLHerdsonPClozapine and constipation: a serious issueAust NZ J Psychiatry1997311149150
   PubMed Web of Science ®Google Scholar
• ShammiCMRemingtonGClozapine-induced necrotizing colitisJ Clin Psychopharmacol19971732302329169975
   PubMed Web of Science ®Google Scholar
• LevinTTBarrettJMendelowitzADeath from clozapine-induced constipation: a case report and literature reviewPsychosomatics2002431717311927763
   PubMed Web of Science ®Google Scholar
• FerslewKEHagardornANHarlanGCMcCormickWFA fatal drug interaction between clozapine and fluoxetienJ Forensic Sci1998435108210859729831
   PubMed Web of Science ®Google Scholar
• FlanaganRJBallRYGastrointestinal hypomobility: an under-recognised life-threatening adverse effect of clozapineForensic Sci Int20112061–3e31e3620719440
   PubMed Web of Science ®Google Scholar